ReviewCNS neuroscience & therapeutics2012
Obesity and psychotropics.
Review in CNS neuroscience & therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder.European journal of clinical pharmacology · 2018Pooled it
- Obesity-associated factors in psychiatric outpatients: A multicenter questionnaire survey.Neuropsychopharmacology reports · 2024Article
- Severe Maternal Morbidity and Maternal Mortality in Women With Intellectual and Developmental Disabilities.American journal of preventive medicine · 2021Article
- Can treatment of obesity reduce depression or vice versa?Journal of psychiatry & neuroscience : JPN · 2021Article
- Weight outcomes in children with developmental disabilities from a multidisciplinary clinic.Research in developmental disabilities · 2021Article
- Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda.BioMed research international · 2019Article
- Mental Illness and Psychotropic Medication use Among People Assessed for Bariatric Surgery in Ontario, Canada.Obesity surgery · 2016Article
- From simplicity towards complexity: the Italian multidimensional approach to obesity.Eating and weight disorders : EWD · 2014Review
- Increase in neuroexcitability of unmyelinated C-type vagal ganglion neurons during initial postnatal development of visceral afferent reflex functions.CNS neuroscience & therapeutics · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Weight gain is on the rise in the United States as is the diagnosis and treatment of mental disorders. These two phenomena are distinctly separate but tend to overlap in that most psychotropic agents approved for use in the United States are associated with the potential to induce weight gain. Metabolic disorders such as diabetes, hypercholesterolemia, and hypertension are also on the rise and often associated with weight gain and clearly associated with certain psychotropic medications. This article serves to provide a succinct review regarding the epidemiology, etiology, and treatment options for psychotropic-induced obesity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.